Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.8K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digitized Health Opens RWE Floodgates. Can Artificial Intelligence Harness the Power?

Managed care (Langhorne, Pa.)·2019
Same authorSame journal

To Be Continued:The Search for a Cure for HIV.

Managed care (Langhorne, Pa.)·2019
Same author

Show Us (the U.S.) the Savings.

Managed care (Langhorne, Pa.)·2019
Same author

Why Biosimilars Can Never Be Identical To Originators-and Why They Don't Need To Be.

Managed care (Langhorne, Pa.)·2019
Same author

Why marijuana is headed for the mainstream.

Managed care (Langhorne, Pa.)·2019
Same author

Rumble Over Drug Rebates As Pharma, Payers Duke It Out.

Managed care (Langhorne, Pa.)·2018

Related Experiment Video

Updated: Feb 5, 2026

Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.6K

Dupixent, a New Entrant In the Asthma Lists.

Thomas Reinke

    Managed Care (Langhorne, Pa.)
    |September 15, 2018
    PubMed
    Summary

    Dupixent (dupilumab) may soon be approved for severe asthma, offering a new monoclonal antibody treatment. This biologic targets type 2 inflammation, joining existing options for severe allergic asthma patients.

    Area of Science:

    • Immunology
    • Pulmonology
    • Pharmacology

    Background:

    • Severe asthma is often characterized by type 2 inflammation.
    • Current biologic therapies target this inflammation, improving patient outcomes.
    • Dupixent (dupilumab) is an established treatment for atopic dermatitis.

    Purpose of the Study:

    • To evaluate the potential approval of Dupixent (dupilumab) for severe asthma.
    • To assess Dupixent's role as a monoclonal antibody for type 2 inflammation in asthma.

    Main Methods:

    • Review of FDA action dates and existing approvals for severe asthma biologics.
    • Analysis of Dupixent's mechanism of action in relation to type 2 inflammation.

    Main Results:

    Keywords:
    AsthmaMedication Managementdupilumab

    More Related Videos

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    32.5K
    Murine Model of Allergen Induced Asthma
    08:05

    Murine Model of Allergen Induced Asthma

    Published on: May 14, 2012

    41.3K

    Related Experiment Videos

    Last Updated: Feb 5, 2026

    Acupuncture in a Rat Model of Asthma
    07:14

    Acupuncture in a Rat Model of Asthma

    Published on: August 25, 2020

    6.6K
    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    32.5K
    Murine Model of Allergen Induced Asthma
    08:05

    Murine Model of Allergen Induced Asthma

    Published on: May 14, 2012

    41.3K
  • Dupixent (dupilumab) has an upcoming FDA action date for its asthma indication.
  • If approved, Dupixent will be a new monoclonal antibody option for severe asthma.

    • Conclusions:

    • Dupixent (dupilumab) is poised to become a new therapeutic option for severe asthma.
    • The drug's approval will expand treatment choices for patients with type 2 inflammation-driven severe asthma.